Cargando…
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T
Small cell lung cancer (SCLC) is a highly aggressive malignancy that accounts for about 14% of all lung cancers. Platinum-based chemotherapy has been the only available treatment for a long time, until the introduction of immune checkpoint inhibitors (ICIs) recently changed first-line standard of ca...
Autores principales: | Guaitoli, Giorgia, Neri, Giovanni, Cabitza, Eleonora, Natalizio, Salvatore, Mastrodomenico, Luciana, Talerico, Sabrina, Trudu, Lucia, Lauro, Chiara, Chiavelli, Chiara, Baschieri, Maria Cristina, Bruni, Alessio, Dominici, Massimo, Bertolini, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656696/ https://www.ncbi.nlm.nih.gov/pubmed/36361523 http://dx.doi.org/10.3390/ijms232112728 |
Ejemplares similares
-
Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations
por: Guaitoli, Giorgia, et al.
Publicado: (2021) -
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature
por: Bruni, Alessio, et al.
Publicado: (2023) -
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
por: Aramini, Beatrice, et al.
Publicado: (2022) -
GD2 CAR T cells against human glioblastoma
por: Prapa, Malvina, et al.
Publicado: (2021) -
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma
por: Golinelli, Giulia, et al.
Publicado: (2021)